Article | March 25, 2019

The Top 5 Questions To Ask When Developing A REMS

Source: United BioSource LLC (UBC)

By Natalie O’Donnell, Executive Director, Safety, Epidemiology, Registries & Risk Management, UBC

A REMS should be considered when risk mitigation efforts are required beyond product labeling and routine pharmacovigilance. This article answers the following questions regarding REMS

  • How do you determine if a REMS is needed during product development?
  • Who from your organization needs to be at the REMS design table?
  • How do you align the products commercial strategy with the REMS?
  • What are the appropriate metrics to assess your REMS?
  • Can you implement a REMS in your organization or should you plan to outsource?

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

United BioSource LLC (UBC)